GABRA2 and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy: Thus, natural variation in GABRA2 expression may contribute to variable expressivity of Dravet syndrome and other epilepsy phenotypes, and possibly contribute to treatment response for drugs that target GABAA receptors.